This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 05/26/2021
Location: Virtual
Subject: The FDA Science Forum: Science as the Foundation for Protecting and Promoting Public Health
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry, media, and other registered guests

Event Date: 05/26/2021
Location: Virtual
Subject: Access! 2021 – Association for Accessible Medicines Annual Meeting; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, media, and other registered guests

Event Date: 05/26/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: Peter Stein
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 05/26/2021
Location: Virtual
Subject: Listening Session with National Alliance for Nutrition and Activity
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Brian Ronholm (Consumer Reports); Madeline Curtis, Tamar Haro, Zach Laris (American Academy of Pediatrics (AAP)); Pepin Tuma (Academy of Nutrition and Dietetics); Jordan Wolfe (American Public Health Association); Thomas Gremillion (Consumer Federation of America); Catherine McMahon (American Cancer Society Action Network); Colin Schwartz, Eva Greenthal (Center for Science in the Public Interest (CSPI)); Brian Dittmeier (National Women's Infants and Children (WIC) Association); Susan Bishop (American Heart Association (AHA));

Event Date: 05/27/2021
Location: Virtual
Subject: COVID-19 Dialogue
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative members of Pharmaceutical Research and Manufacturers Association (PhRMA)

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 05/27/2021
Location: Virtual
Subject: Generic Drug User Fee Act (GDUFA) Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from industry and congressional staff

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/26/2021
Location: Virtual
Subject: Euro Servizi Impressa (ESI) and Italian Food Industrial Trade Association Webinar on Food Safety Culture
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Italian food industry, trade associations, and academia

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 05/26/2021
Location: Virtual
Subject: Alliance to Stop Foodborne Illness Annual Session; Speaker
FDA Participant/Group: JUDITH MCMEEKIN;
Non FDA Participant/Group: Industry, and other stakeholders

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 05/25/2021
Location: Virtual
Subject: Amyotrophic Lateral Sclerosis (ALS) Patient-Led Listening Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, patient advocacy groups, and other stakeholders

Event Date: 05/25/2021
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar; Speaker: CDER Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, patient advocacy groups, and other stakeholders

Event Date: 05/27/2021
Location: Virtual
Subject: BIO Digital Session Recording - FDA Town Hall
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Richard Pops (Alkermes);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/26/2021
Location: Virtual
Subject: International Society for Cell and Gene Therapy / World Health Organization Virtual Annual Meeting; Integrating Science, Reg. Oversight, and Commercialization for the New Wave of Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, academia, and other stakeholders

Event Date: 05/26/2021
Location: Virtual
Subject: International Society for Cell and Gene Therapy / World Health Organization Virtual Annual Meeting; Naming Cell and Gene Therapies - Harmonizing With International Nonproprietary Names (INN)
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, academia, and other stakeholders

Event Date: 05/26/2021
Location: Virtual
Subject: Montgomery County Chamber of Commerce; Accelerating Medical Product Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Montgomery County Chamber of Commerce board of directors

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event